Skip to main content

FDA recall, , Moderate risk

HeartSine Samaritan PAD Defibrillators SAM 350P, SAM 360P and SAM 450P

HeartSine SAM 350P, SAM 360P, and SAM 450P defibrillators have a damaged membrane tail causing an intermittent fault.

What happened

HeartSine Technologies Ltd of Belfast, United Kingdom recalled HeartSine SAM 350P, SAM 360P, and SAM 450P devices because a damaged (over stretched) membrane tail causes an intermittent fault. The FDA added the recall to its Enforcement Report on September 4, 2026, and the company began the recall on July 27, 2026. Distribution included U.S. nationwide states such as Alaska, California, Florida, and New York, and worldwide countries including Canada, Japan, and the United Kingdom.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Affected if its UDI-DI is listed.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. SAM 450P US Device, US English (2 min CPR)

    UDI-DI
    • 0506016712069
  2. 350P US Device, US English - 2 Min CPR

    UDI-DI
    • 0506016712067
  3. 350P US Device, US English (American Airlines) - 2 Min CPR

    UDI-DI
    • 0506016712207
  4. 350P US Device, US English with Gateway - 2 Min CPR

    UDI-DI
    • 0506016712804
  5. 360P US Device, US English - 2 Min CPR

    UDI-DI
    • 0506016712068

Recall details

Company began the recall
Sold in

Worldwide - U.S. Nationwide distribution including in the states of Alaska, Alabama, Arizona, California, Connecticut, District of Columbia, Florida, Georgia, Hawaii, Iowa, Idaho, Illinois, Indiana, Kansas, Kentucky, Massachusetts, Maryland, Maine Michigan, Minnesota, North Carolina, New Jersey, New Mexico, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, South Dakota,Tennessee, Texas, Utah, Virginia, Washington, Wisconsin, West Virginia and Wyoming. The countries of Argentina, Australia, Brazil, Canada, Chile, Colombia, Hong Kong, Indonesia, ISRAEL, JAPAN, Malaysia, Netherlands, Philippines, POLAND, SINGAPORE, South Korea, Taiwan, Thailand and UNITED KINGDOM.

Company
HeartSine Technologies LtdBelfast, United Kingdom
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99568
Recall number
Z-3120-2026

All recalls from HeartSine Technologies Ltd

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)